Share on StockTwits

Oragenics (NASDAQ:OGEN) announced its earnings results on Thursday. The company reported ($0.05) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.09) by $0.04, Stock Ratings Network reports.

Shares of Oragenics (NASDAQ:OGEN) opened at 1.82 on Thursday. Oragenics has a one year low of $1.56 and a one year high of $4.65. The stock’s 50-day moving average is $2.19 and its 200-day moving average is $2.92. The company’s market cap is $65.8 million.

Oragenics, Inc is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.